Reason for clozapine cessation

Acta Psychiatrica Scandinavica

Volumn 125, Issue 1, 2012, Pages 39-44

  Pai, N B ^a   Vella, S C ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Clozapine; Patient's motives; Schizophrenia; Treatment cessation

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CARDIOTOXICITY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PREGNANCY; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; DRUG TOXICITY; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MOTIVATION; NEUTROPENIA; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 83555173366     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01776.x     Document Type: Article

References (21)

1. Conley R, Buchananr RW. Evaluation of treatment-resistant schizophrenia. Schizophr Bull 1997;23:663-674.
2. Semiz U, Cetin M, Basoglu C et al. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1330-1336.
3. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 1988;45:789-796.
4. Weinbrenner S, Assion H, Stargardt T, Busse R, Juckel G, Gericke C. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund. Pharmacopsychiatry 2008;41:1-6.
5. Nielsen J, Damkier P, Lublin H, Taylor D. Optimizing clozapine treatment. Acta Psychiatr Scand 2011;123:411-422.
6. Vella S, Pai N. A pharmacoepidemiological analysis of clozapine use in a region of Australia. Acta Psychiatr Scand 2011;124:413-414.
7. Nielsen J, Dahmm M, Lublin H, Taylor D. Psychiatrists attitude towards and knowledge of schizophrenia treatment. J Psychopharmacol 2010;24:965-971.
8. Reznik I, Volchek L, Mester R et al. Myotoxicity and neurotoxicity during clozapine treatment. Clin Neuropharmacol 2000;23(5):276-280.
9. Skeleton J, Pepe M, Pineo T. How much better is clozapine? A meta-analytic review and critical appraisal Exp Clin Psychopharmacol 1995;3:270-279.
10. Drew LRH, Griffiths K, Hodgson D. A five year follow-up study of the use of clozapine in a community practice. Aust N Z J Psychiatry 2002;36:780-786.
11. Wheeler A, Humberstone V, Robinson G. Outcomes for schizophrenia patients with clozapine treatment: how good does it get? J Psychopharmacol 2009;23:957-965.
12. Henneen J, Baldessarini R. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res 2005;73:139-145.
13. Kane JM. A user' guide to clozapine. Acta Psychiatr Scand 2011;123:407-408.
14. Young C, Bowers M, Mazure C. Management of the adverse effects of clozapine. Schizophr Bull 1998;24:381-390.
15. Patel M, de Zoysa N, David A. Cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry 2008;69(10):1548-1556.
16. Zygmunt A, Olfson M, Boyer C, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653-1654.
17. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12760 clozapine recipients in the UK and Ireland. Br J Psychiatry 1999;175:576-580.
18. Whiskey E, Wykes T, Duncan-Mcconnell D, Haworth E, Walsh N, Hastilow S. Continuation of clozapine treatment: practice makes perfect. Psychiatrist, 2003;27:211-213.
19. Taylor D, Douglas-Hall P, Olofinjana B, Whiskey E, Thomas A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-lasting injection. Br J Psychiatry 2009;94:165-167.
20. Patel N, Dorson P, Bettinger T. Sudden onset of clozapine-induced agranulocytosis. Ann Pharmacother 2002;36(6):1012-1015.
21. Latif Z, Jabbar F, Kelly BD. Clozapine and blood dyscrasia. Psychiatrist 2011;35:27-29.